The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1361
In Brief: PPIs and Hypomagnesemia
Download PDF:   US English
Med Lett Drugs Ther. 2011 Apr 4;53(1361):25
Disclosures
Objective(s)
 Select a term to see related articles  Hypomagnesemia   Proton pump inhibitors 

The FDA has warned that prolonged use of a proton pump inhibitor (PPI) can lead to hypomagnesemia.1 Normal serum concentrations of magnesium are 0.7-1.0 mmol/L. About 30 cases of severe hypomagnesemia (<0.5 mmol/L) have been reported in long-term PPI users; when the PPI was stopped, serum magnesium levels returned to normal in less than 2 weeks.2-5 The exact mechanism is unknown, but in some patients PPIs apparently interfere with active transport of magnesium across the intestinal wall or cause excessive loss into the intestinal lumen.6 Hypomagnesemia is often accompanied by hypocalcemia and hypokalemia. Symptoms can include muscle weakness, tremor, muscle cramps, carpopedal spasm, tetany, seizures, and cardiac conduction disturbances and arrhythmias. Most patients who take PPIs for a long time do not develop hypomagnesemia, and those with hypomagnesemia often do not have symptoms. Patients also taking other drugs that cause hypomagnesemia, such as diuretics and digoxin, may be at increased risk.

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article
arrow to next article